Skip to main content

Advertisement

Log in

An autopsy case of adult-onset hereditary spastic paraplegia type 2 with a novel mutation in exon 7 of the proteolipid protein 1 gene

  • Case Report
  • Published:
Acta Neuropathologica Aims and scope Submit manuscript

Abstract

We report an autopsy case of rare adult-onset spastic paraplegia type 2 (SPG2) with a novel missense mutation in exon 7 of the proteolipid protein 1 gene (PLP1). The patient was a 67-year-old man whose elder brother had died of a similar disease with onset in his 40s. Thirty-three years before death at the age of 35, he noticed difficulty in walking. He gradually became abasic over a period of 6 years. He also developed progressive dementia and eventually became bed-ridden by 28 years after onset. At autopsy, gross inspection revealed diffuse, moderate atrophy of the cerebrum with a dilated ventricular system and softening of the white matter throughout the central nervous system (CNS). Histopathologically, the CNS showed widespread myelin pallor in the white matter. By contrast, the gray matter and peripheral nerves were well preserved. Some white matter tracts, including the corticospinal tracts, were preferentially affected, and severe axonal degeneration was observed in these tracts. Genetic analysis revealed a novel mutation, p.Tyr263Cys, in exon 7 of PLP1. This case represents an adult-onset SPG2 patient with one of the oldest ages of onset reported to date. The late onset and long clinical course suggest that this novel mutation does not affect the maturation of oligodendrocytes, but is related to insufficient maintenance of myelin.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

References

  1. Cailloux F, Gauthier-Barichard F, Mimault C et al (2000) Genotype-phenotype correlation in inherited brain myelination defects due to proteolipid protein gene mutations. Clinical European network on brain dysmyelinating disease. Eur J Hum Genet 8:837–845

    Article  PubMed  CAS  Google Scholar 

  2. Fink JK, Heiman-Patterson T, Bird T et al (1996) Hereditary spastic paraplegia: advances in genetic research. Hereditary Spastic Paraplegia Working group. Neurology 46:1507–1514

    PubMed  CAS  Google Scholar 

  3. Garbern JY (2007) Pelizaeus-Merzbacher disease: genetic and cellular pathogenesis. Cell Mol Life Sci 64:50–65

    Article  PubMed  CAS  Google Scholar 

  4. Garbern JY, Yool DA, Moore GJ et al (2002) Patients lacking the major CNS myelin protein, proteolipid protein 1, develop length-dependent axonal degeneration in the absence of demyelination and inflammation. Brain 125:551–561

    Article  PubMed  Google Scholar 

  5. Gow A, Friedrich VL Jr, Lazzarini RA (1994) Many naturally occurring mutations of myelin proteolipid protein impair its intracellular transport. J Neurosci Res 37:574–583

    Article  PubMed  CAS  Google Scholar 

  6. Gow A, Lazzarini RA (1996) A cellular mechanism governing the severity of Pelizaeus–Merzbacher disease. Nat Genet 13:422–428

    Article  PubMed  CAS  Google Scholar 

  7. Gow A, Sharma R (2003) The unfolded protein response in protein aggregating diseases. Neuromol Med 4:73–94

    Article  CAS  Google Scholar 

  8. Griffiths I, Klugmann M, Anderson T et al (1998) Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. Science 280:1610–1613

    Article  PubMed  CAS  Google Scholar 

  9. Grossi S, Regis S, Biancheri R et al (2011) Molecular genetic analysis of the PLP1 Gene in 38 families with PLP1-related disorders: identification and functional characterization of 11 Novel PLP1 mutations. Orphanet J Rare Dis 6:40

    Article  PubMed  Google Scholar 

  10. Hodes ME, Blank CA, Pratt VM, Morales J, Napier J, Dlouhy SR (1997) Nonsense mutation in exon 3 of the proteolipid protein gene (PLP) in a family with an unusual form of Pelizaeus–Merzbacher disease. Am J Med Genet 69:121–125

    Article  PubMed  CAS  Google Scholar 

  11. Hodes ME, Zimmerman AW, Aydanian A et al (1999) Different mutations in the same codon of the proteolipid protein gene, PLP, may help in correlating genotype with phenotype in Pelizaeus–Merzbacher disease/X-linked spastic paraplegia (PMD/SPG2). Am J Med Genet 82:132–139

    Article  PubMed  CAS  Google Scholar 

  12. Hudson LD, Berndt JA, Puckett C, Kozak CA, Lazzarini RA (1987) Aberrant splicing of proteolipid protein mRNA in the dysmyelinating jimpy mutant mouse. Proc Natl Acad Sci USA 84:1454–1458

    Article  PubMed  CAS  Google Scholar 

  13. Hudson LD, Friedrich VL Jr, Behar T, Dubois-Dalcq M, Lazzarini RA (1989) The initial events in myelin synthesis: orientation of proteolipid protein in the plasma membrane of cultured oligodendrocytes. J Cell Biol 109:717–727

    Article  PubMed  CAS  Google Scholar 

  14. Inoue K (2005) PLP1-related inherited dysmyelinating disorders: Pelizaeus–Merzbacher disease and spastic paraplegia type 2. Neurogenetics 6:1–16

    Article  PubMed  CAS  Google Scholar 

  15. Iwaki A, Muramoto T, Iwaki I et al (1993) A missense mutation in the proteolipid protein gene responsible for Pelizaeus–Merzbacher disease in a Japanese family. Hum Mol Genet 2:19–22

    Article  PubMed  CAS  Google Scholar 

  16. Kobayashi H, Hoffman EP, Marks HG (1994) The rumpshaker mutation in spastic paraplegia. Nat Genet 7:351–352

    Article  PubMed  CAS  Google Scholar 

  17. Kurosawa K, Iwaki A, Miyake S, Imaizumi K, Kuroki Y, Fukumaki Y (1993) A novel insertional mutation at exon VII of the myelin proteolipid protein gene in Pelizaeus–Merzbacher disease. Hum Mol Genet 2:2187–2189

    Article  PubMed  CAS  Google Scholar 

  18. Lee ES, Moon HK, Park YH, Garbern J, Hobson GM (2004) A case of complicated spastic paraplegia 2 due to a point mutation in the proteolipid protein 1 gene. J Neurol Sci 224:83–87

    Article  PubMed  CAS  Google Scholar 

  19. Osaka H, Koizume S, Aoyama H et al (2010) Mild phenotype in Pelizaeus–Merzbacher disease caused by a PLP1-specific mutation. Brain Dev 32:703–707

    Article  PubMed  Google Scholar 

  20. Saugier-Veber P, Munnich A, Bonneau D et al (1994) X-linked spastic paraplegia and Pelizaeus–Merzbacher disease are allelic disorders at the proteolipid protein locus. Nat Genet 6:257–262

    Article  PubMed  CAS  Google Scholar 

  21. Sima AA, Pierson CR, Woltjer RL et al (2009) Neuronal loss in Pelizaeus–Merzbacher disease differs in various mutations of the proteolipid protein 1. Acta Neuropathol 118:531–539

    Article  PubMed  Google Scholar 

  22. Sivakumar K, Sambuughin N, Selenge B et al (1999) Novel exon 3B proteolipid protein gene mutation causing late–onset spastic paraplegia type 2 with variable penetrance in female family members. Ann Neurol 45:680–683

    Article  PubMed  CAS  Google Scholar 

  23. Southwood CM, Garbern J, Jiang W, Gow A (2002) The unfolded protein response modulates disease severity in Pelizaeus–Merzbacher disease. Neuron 36:585–596

    Article  PubMed  CAS  Google Scholar 

  24. Thomson CE, Montague P, Jung M, Nave KA, Griffiths IR (1997) Phenotypic severity of murine Plp mutants reflects in vivo and in vitro variations in transport of PLP isoproteins. Glia 20:322–332

    Article  PubMed  CAS  Google Scholar 

  25. Woodward KJ (2008) The molecular and cellular defects underlying Pelizaeus–Merzbacher disease. Expert Rev Mol Med 10:e14

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported in part by a Health and Labour Sciences Research Grant from the Ministry of Health, Labour and Welfare of Japan (A.I.). The authors thank Ms. Sachiko Koyama (Dept. of Neuropathology, Kyushu University) for her excellent technical support.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Satoshi O. Suzuki.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Suzuki, S.O., Iwaki, T., Arakawa, K. et al. An autopsy case of adult-onset hereditary spastic paraplegia type 2 with a novel mutation in exon 7 of the proteolipid protein 1 gene. Acta Neuropathol 122, 775–781 (2011). https://doi.org/10.1007/s00401-011-0916-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00401-011-0916-x

Keywords

Navigation